Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ACRSACRS
Showing 8 of 29 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ACLARIS THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS holds 35,524 shares of ACRS (ACLARIS THERAPEUTICS INC), worth $187,922 as of 2026-Q2. The position was increased (+65.7% shares). ACRS represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$187,922

Current Shares

35,524

Total Value Change

+$184,164

Total Shares Change

+32,256

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
35,524
+65.7%
$187,9220.0%$5.29
33
2026-Q1
Decreased
21,445
-0.3%
$80,4190.0%$3.04
0
2025-Q4
Decreased
21,516
-19.3%
$64,7630.0%$2.90
0
2025-Q3
Increased
26,667
+59.0%
$50,6670.0%$1.92
20
2025-Q2
Increased
16,773
+124.3%
$23,8180.0%$1.47
21
2025-Q1
Increased
7,479
+417.2%
$11,4430.0%$1.59
19
2024-Q4
Decreased
1,446
-55.8%
$3,5860.0%$2.48
0
2024-Q3
Decreased
3,268
-3.9%
$3,7580.0%$1.17
0

Other major holders of ACRS: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used